Thermo Fisher Scientific and BrainMet Centre Collaborate on Dementia Research

BrainMet (Bioimaging of Metals in Brain and Metallomics) Centre at Forschungszentrum, Jülich, Germany is advancing is advancing dementia research by studying the effects of metals and metalloproteins in ageing and in the origin of neurodegenerative diseases like Alzheimer’s and Parkinson’s diseases and Wilson’s syndrome. To carry out this challenging research in the BrainMet laboratory (www.brainmet.com), a Thermo Scientific XSERIES 2 inductively coupled plasma mass spectrometer (ICP-MS) was installed, combining third-generation collision cell and protective ion extraction technologies with an ergonomic, compact design.

Dr. habil. J. Sabine Becker, comments: “We are delighted to have entered into this exciting collaboration with Thermo Fisher. The state-of-the-art XSERIES 2 has been extremely efficient for quantitative bioimaging of metals of healthy and diseased samples of brain tissue and also for investigating the growth of brain tumors and strokes. Our ultimate goal is to advance dementia research and help the pharmaceutical industry introduce new therapies. The XSERIES 2 is very reliable and easy to use while providing the high signal to background ratio and excellent sensitivity that is required for our research.” Thermo Fisher Scientific.